baber/WOPTO huggingface dataset:
Patent JP-3403787-B2 (JP)
IPC: C06B27/00
Filed: 1993-11-26
Granted: 2003-05-06
Abstract: A pyrotechnic delay charge for providing delays in the millisecond and second ranges, comprising the components bismuth oxide as an oxidation agent and silicon as a fuel. The invention also relates to a pyrotechnic delay element having an enclosure containing the pyrotechnical delay charge, and to a detonator having a housing, ignition means disposed at one end of the housing, a base charge of a secondary explosive disposed at the other end of the housing and the pyrotechnic delay charge disposed therebetween.
Patent JP-H0472751-B2 (JP)
IPC: G01P3/42
Filed: 1987-12-28
Abstract: A system determines the movement of a track vehicle along the ground, the track vehicle having at least a first rotatable, endless track for supporting the vehicle on the ground, a drive for causing the movement of the vehicle, and a turning system for changing the direction of the movement of the vehicle. The system has a first traction-improvement device for mounting on the track vehicle. It bears on an inner-surface side of the first track with sufficient pressure for a small-surface portion on the opposite side of the first track to engage the ground with a higher pressure than any other portion of the first track, whereby to locate a pivoting axis of the track vehicle in the vicinity thereof. A first speed sensor for mounting on the track vehicle in the vicinity of the small-surface portion on the opposite side of the first track senses the speed of movement of the track vehicle along the ground only in the direction of the rotation of the first track and provides a first information thereof, whereby the movement of the track vehicle may be deduced therefrom. Preferably the vehicle has two tracks, and the system has two such traction-improvement devices and speed sensors respectively for the two tracks.
Patent JP-2990376-B2 (JP)
Title: Folded scaffolding and adjusting method for height thereof
Inventor: SHIRAI SHOICHI
IPC: E04G1/34
Filed: 1990-11-30
Granted: 1999-12-13
Abstract: A compact folding type scaffolding apparatus applicable to a wide variety of indoor applications in which elevated working platforms are required to be set up quickly and simply comprises planks (1) hinged centrally and main legs (2) at each corner. A pair of central legs (3) support the planks in a working condition (Figure 1) and a slidable bracket (7) for links (8) is provided on each central leg. Further brackets (4) are pivotally connected between the legs (2, 3). The whole apparatus is folded so that the planks (1) define a storage space for the legs and links therebetween (Figure 3). <IMAGE>
Patent JP-2974789-B2 (JP)
IPC: C08F4/646
Filed: 1990-12-25
Granted: 1999-11-10
Abstract: Catalyst components for the polymerization of olefins and catalysts obtained therefrom, said components comprising a porous metal oxide on which a magnesium dihalide, and a titanium halide or titanium halogen alcoholate and a compound containing two or more ether groups having specific reactivity properties towards MgCl2 and TiCl4 are supported.
Patent JP-2854058-B2 (JP)
IPC: G01N33/554
Filed: 1988-11-30
Granted: 1999-02-03
Abstract: The invention provides methods for separating bound label from unbound label within an assay mixture, for predispensing assay reactants in self-contained assay vessels, as well as for detecting the presence and/or amount of an analyte within a fluid sample. In addition, a reusable detection vessel for use therein and with specific binding assays in general is disclosed. In the methods, generally an analyte within a sample is detected or measured by forming an assay mixture containing sample, analyte binding components and label, placing the assay mixture in contact with an immisable primary layer, subjecting the assay mixture to conditions that separate the analyte bound with binding components and label from unbound binding components and label, and subsequently detecting bound label.
Patent JP-H07118239-B2 (JP)
IPC: B29C45/14
Filed: 1984-03-23
Abstract: PCT No. PCT/FR84/00077 Sec. 371 Date Oct. 30, 1984 Sec. 102(e) Date Oct. 30, 1984 PCT Filed Mar. 23, 1984 PCT Pub. No. WO84/03794 PCT Pub. Date Sep. 27, 1984.A method of molding the insulating covering of an organic electrical insulator comprising a long central rod (3) having end fittings (5, 6). Retractable supports (11, 12, 21, 22) are disposed at regular intervals along an injection mold for the covering. The covering is injected, and at the end of injection, prior to vulcanization, the supports are retracted. The voids left in the mold (1, 2) by the supports are instantly filled by the injected material. Protective sleeves (24, 25) are interposed between the rod and the said supports.
Patent JP-3351525-B2 (JP)
IPC: A61P43/00
Filed: 1992-06-22
Granted: 2002-11-25
Abstract: PCT No. PCT/US92/05309 Sec. 371 Date Jun. 29, 1993 Sec. 102(e) Date Jun. 29, 1993 PCT Filed Jun. 22, 1992 PCT Pub. No. WO93/00050 PCT Pub. Date Jan. 7, 1993A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and an osteogenic protein-sequestering material.
Patent JP-H0349575-B2 (JP)
IPC: A61F2/06
Filed: 1982-09-15
Abstract: An arrangement, for surgical or medicinal use, involving a spiral spring (l) together with a device through which this can be made to expand from a first position (fig.3; 5) with a certain diameter, to a second position (fig.2; 4) with a larger diameter and vice versa; whereby the device (4l, 42b, 43) is designed , whilst keeping the same length (L) on the spring (1; 36) , to turn the spring's ends (38, 39) relative to each other so that the transition from said first position to said second position takes place through a reduction in the number of turns in the spring within said length (L) and a corresponding increase in the spring's ascent (s) or, in order to supply further spring material (B) for a given length (L4) of the spring  (1), on at least one end of the spring's (1) said length (L4) so that the transition from said first position to said second position takes place independently of the extension and the number of turns of the spring within said length (L4).<IMAGE>
Patent JP-2677850-B2 (JP)
IPC: A61L31/00
Filed: 1988-04-21
Granted: 1997-11-17
Abstract: PCT No. PCT/GB88/00301 Sec. 371 Date Oct. 17, 1989 Sec. 102(e) Date Oct. 17, 1989 PCT Filed Apr. 21, 1988 PCT Pub. No. WO88/08311 PCT Pub. Date Nov. 3, 1988.Gloves, expecially those of the type worn by surgeons, and fabricated from elastomeric materials have a hand conducting surface comprising an ionic polyurethane to render the glove hyopallergenic. The surface modifying composition may comprise a blend of an ionic polyurethane and a second polymer, e.g. another polyurethane or an acrylic polymer wherein the particle size of the second polymer are greater than that of the best ionic polyurethane. The use of blends enables donning of the glove to be effected without the aid of donning powder such as starch or talc.
Patent JP-3214861-B2 (JP)
IPC: A23L19/12
Filed: 1997-07-01
Granted: 2001-10-02
Abstract: Dehydrated potato flakes prepared from potato slices, slivers and/or nubbins suitable for use in dough compositions used to make fabricated products. The dehydrated flakes are prepared such that the physical properties in the flake are controlled during processing. The resulting flakes can be used to prepare a more cohesive, non-adhesive, machineable dough. <IMAGE>
Patent JP-4326591-B2 (JP)
IPC: G06F3/033
Filed: 1996-07-26
Granted: 2009-09-09
Abstract: A reduced keyboard disambiguating system (50) having a keyboard (54) with a reduced number of keys. A plurality of letters and symbols are assigned to a set of data keys (56) so that keystrokes entered by a user are ambiguous. Due to the ambiguity in each keystroke, an entered keystroke sequence could match a number of words with the same number of letters. The disambiguating system includes a memory (104) having a number of vocabulary modules (110). The vocabulary modules contain a library of objects that are each associated with a keystroke sequence. Each object is also associated with a frequency of use. Objects within the vocabulary modules that match the entered keystroke sequence are identified by the disambiguating system. Objects associated with a keystroke sequence that match the entered keystroke sequence are displayed to the user in a selection list (76). The objects are listed in the selection list according to their frequency of use. An unambiguous select key (60) is pressed by a user to delimit the end of a keystroke sequence. The first entry in the selection list is automatically selected by the disambiguating system as the default interpretation of the ambiguous keystroke sequence. The user accepts the selected interpretation by starting to enter another ambiguous keystroke sequence. Alternatively, the user may press the select key a number of times to select other entries in the selection list. For words that are not in the vocabulary modules, a two-stroke or multiple-stroke method are used to unambiguously specify each letter. The disambiguating system simultaneously interprets all entered keystroke sequences as a word, as a two-stroke sequence, and as a multiple-stroke sequence. The multiple interpretations are automatically and simultaneously provided to the user in the selection list.
Patent JP-3897364-B2 (JP)
IPC: B65B9/04
Filed: 1997-08-01
Granted: 2007-03-22
Abstract: A system for triggering an oxygen scavenging film includes the means for emitting UV-C light, means associated with said light defining a film path, means for feeding an oxygen scavenging film into the system to trigger the oxygen scavenging film, means for feeding the triggered film to packaging means. The film may comprise an oxidizable organic compound and a transition metal catalyst.</PTEXT>
Patent JP-2800848-B2 (JP)
IPC: A61K31/70
Filed: 1991-04-15
Granted: 1998-09-21
Abstract: Methods for modulating the expression of genes are disclosed comprising selecting a portion RNA coded by the gene, said RNA portion having subportions forming a secondary structure, and contacting the RNA with oligonucleotide or oligonucleotide analog which can bind with at least one said subportions of the RNA. In accordance with the preferred embodiments, oligonucleotides or oligonucleotide analogs are designed to bind to RNA secondary structures which are of significance to the expression of the gene coding for said RNA. In accordance with a preferred embodiment, methods of treatment of human immunodeficiency virus are similarly disclosed wherein the oligonucleotides or oligonucleotide analogs are targeted at the TAR, CAR or gag-pol elements of HIV. <IMAGE>   <IMAGE>
Patent JP-3194434-B2 (JP)
IPC: A61B5/00
Filed: 1991-04-17
Granted: 2001-07-30
Abstract: Implantable enzymatic sensors (25, 43, 44) for biochemicals such as glucose are provided having an ideal size and geometry for optional long term implantation and linear responses over the concentration ranges of interest. The sensors (25, 43, 44) include an elongated body (10, 26, 46) supporting an indicating electrode section having an appropriate enzyme immobilized thereon to present an enzymatic indicating surface (21, 33, 54). A permeable synthetic polymer membrane (24, 42, 56) is applied over the sensor body (10, 26, 46) to protect the enzyme and regulate diffusion of analyte therethrough, to ensure linearity of sensor response. The sensors (25, 43) are of flexible design and can be implanted using a catheter. Alternately, the sensor (44) includes an internal indicating electrode body (46) housed within an apertured, hollow needle (48). A holder (66) affixed to the needle (48) allows for easy manipulation and implantation of the sensor (44).
Patent JP-4142743-B2 (JP)
IPC: A61P43/00
Filed: 1997-07-30
Granted: 2008-09-03
Abstract: The present invention relates to novel PTHrP analogs that have been converted into potent PTH-2 receptor agonists or antagonists by the substitution of one or more amino acid residues of PTHrP to the corresponding residue(s) of PTH. A method of treating various disease states associated with altered function of the PTH-2 receptor, using these PTHrP analogs, is also described.
Patent JP-3072527-B2 (JP)
IPC: A61K31/122
Filed: 1995-09-07
Granted: 2000-07-31
Abstract: An agent for depressing and inhibiting the functions developed by the multidimensional structure (conformation) of a molecule through a nonenzymatic reaction. Examples thereof include a compound having a fundamental molecular structure represented by general formula (a), and other agents containing the compound, a derivative thereof or an acid-addition salt thereof as the active ingredient, such as antibacterial agent, antifungal agent, antiviral agent, germicide/disinfectant, anticancer drug, blood-clotting/fibrinolytic system depressant or inhibitor, antigen-antibody reaction depressant, organ-tissue preservative or antiseptic for food, etc., spermatocide or contraceptive for external use, thrombolytic agent, sugar-chain conformation modifier, arteriosclerosis preventive, improver for (lipid, sugar or protein) metabolism, wound healing agent, epithelialization accelerator, depressant of function development of bioactive substances (such as enzyme, peptide and gene), depolymerizer, surface activity improver, phase transfer agent or phase transfer improver, micro-phase separate structure improver, plasticizer or plasticity improver, copolymerizing agent or copolymerization improver, polymerization regulator or polymerization regulator/improver, stabilizer or stabilization improver, noncrystallizer or noncrystallizability improver, fluidity improver, flexibilizer or flexibilization improver, oxidation inhibitor antioxidant, modifier or improver of the fluorescence wavelength or excitation wavelength of dye, paint, pigment or colorant, improver of properties or functions of low-molecular-weight substance, improver of properties or functions of high-molecular-weight substance, and improver of properties of high-molecular-weight composite material or functional high-molecular-weight composite material. <CHEM>
Patent JP-2934310-B2 (JP)
IPC: A61H37/00
Filed: 1990-06-19
Granted: 1999-08-16
Abstract: An apparatus for full length and localized massage of a user's body includes a bed structure having a housing defining an interior chamber, a liquid reservoir basin beneath the chamber, and an upwardly-facing opening horizontally across which a resiliently flexible membrane is sealingly affixed in tensioned condition to form a user body support surface. The reservoir basin contains a quantity of a massage liquid, preferably water, with the remainder of the chamber being filled with air. A massage head having multiple liquid emission openings therein is disposed within the chamber for lengthwise traversing travel with the emission openings facing the membrane. A pump communicates with the reservoir basin and with a downstream series of conduits connected to the massage head for withdrawing the massage liquid from the reservoir basin and supplying the liquid under pressure to the massage head for emission against the underside of the membrane to transmit a massaging effect to the body of a user laying thereon.
Patent JP-3262333-B2 (JP)
IPC: C07D413/02
Filed: 1992-12-01
Granted: 2002-03-04
Abstract: This invention concerns compounds of formula (I)  in optionally substituted by lower alkyl; Z is a bicyclic oxygen-containing aryl radical (e.g. 2,3-dihydro-1,4-benzodioxin-5-yl); R is hydrogen or lower alkyl; R1 is aryl or aryl(lower)alkyl; R2 is hydrogen or lower alkyl; and R3 is hydrogen, an alkyl group of 1 to 10 carbon atoms, cycloalkyl of 3 to 12 carbon atoms; cycloalkyl(lower)alkyl, aryl or aryl(lower)alkyl or R2 and R3 together with the nitrogen atom to which they are both attached represent a saturated heterocyclic ring which may contain a further hetero atom, and the pharmaceutically acceptable acid addition salts thereof. The compounds are 5-HT1A-antagonists which may be used, for example, in treating anxiety.
Patent JP-3483881-B2 (JP)
IPC: A61K9/70
Filed: 1992-05-27
Granted: 2004-01-06
Abstract: Salts of medetomidine and optically active enantiomers, thereof, particularly the d-enantiomer are disclosed. These salts may be used to regulate the rate of the transdermal administration of active drugs. The transdermal delivery system comprises a drug impermeable backing layer and an adhesive layer wherein the medetomidine is dispersed throughout the adhesive layer.
Patent JP-3001257-B2 (JP)
IPC: C01G19/00
Filed: 1990-07-20
Granted: 2000-01-24
Abstract: The invention provides a method of making alkali metal stannates which comprises heating a mixture of tin oxide with a solution of alkali under pressure. Preferably a stoichiometric excess of alkali over the tin is used.
Patent JP-3764477-B2 (JP)
IPC: B29C45/26
Filed: 1993-12-02
Granted: 2006-04-05
Abstract: Apparatus for the preparation of optical ferrules containing cylindrical members is disclosed. The apparatus utilizes guide means receiving the cylindrical member, a sleeve receiving a piston therethrough, and a pin extending into the sleeve. The apparatus also includes biasing means to position the piston, fill gates to dispense polymer into a defined cavity, and containment means which secure the apparatus components together. Injection molded optical fiber ferrules made according to the apparatus and process disclosed exhibit superior properties.
Patent JP-3147237-B2 (JP)
IPC: A61K35/74
Filed: 1990-09-14
Granted: 2001-03-19
Abstract: The present invention concerns a pharmaceutical composition for treating malignancies and autoimmune diseases involving cells expressing MHC class II antigens. The composition comprises a substance making said cells targets for cytotoxic T cells. The substance may be selected from the group consisting of staphylococcal enterotoxines, toxoids, active fragments or peptides of said enterotoxins and substances having essentially the same mode of action, such as Toxic Shock Syndrome toxins (TSST-1), bacterial exoproteins, such as streptococcal exoproteins, and proteins produced by mycoplasma arthritidis, which have capacity to interact with parts of the TCR and specifically the V beta chains thereof.
Patent JP-3499872-B2 (JP)
IPC: G01N27/44
Filed: 1993-12-21
Granted: 2004-02-23
Abstract: The invention provides an electrochemical reaction wherein a controlled amount of a first reagent is generated electrochemically at an electrode in electrical contact with a solution of an electrochemically inert salt, comprising applying a suitable electrical potential to the electrode for a suitable time to generate a controlled amount of the first reagent by electrochemical reaction between the electrode and a species in solution producing a localized thin layer environment comprising the first reagent in the vicinity of the electrode; and monitoring the amount or presence of the first reagent or a further species produced in solution in response to production of the first reagent. The method invention thus involves generating the first reagent in situ at an electrode. Diffusion of the reagent in solution surrounding the electrode will result in creation of a localized environment of the reagent in the vicinity of the electrode, with the amount of reagent depending on the generating current and the length of time for which it is applied, and so being readily and easily controllable.
Patent JP-2810547-B2 (JP)
IPC: H01F41/10
Filed: 1995-03-26
Granted: 1998-10-15
Abstract: PCT No. PCT/DE95/00416 Sec. 371 Date Sep. 20, 1996 Sec. 102(e) Date Sep. 20, 1996 PCT Filed Mar. 26, 1995 PCT Pub. No. WO95/26538 PCT Pub. Date Oct. 5, 1995Procedure for producing a transponder unit (55) provided with at least one chip (16) and one coil (18), and in particular a chip card/chip-mounting board (17) wherein the chip and the coil are mounted on one common substrate (15) and the coil is formed by installing a coil wire (21) and connecting the coil-wire ends (19, 23) to the contact surfaces (20, 24) of the chip on the substrate.
Patent JP-4077520-B2 (JP)
IPC: G11B19/28
Filed: 1997-12-16
Granted: 2008-04-16
Abstract: An improved method and apparatus for maintaining a recording head in an optical recording system at a constant linear velocity relative to a rotatable disk support. A rotation controller uses a cumulative measure of rotation to determine an angular velocity of the rotating disk support necessary to maintain a constant linear velocity.
Patent JP-3343659-B2 (JP)
IPC: G09F3/00
Filed: 1997-02-18
Granted: 2002-11-11
Abstract: An identification wristband is fabricated from transparent synthetic plastic and has a flattened central area wherein the inner surfaces of the central area are relatively close to each other and opposite edges communicating with the central area, which are substantially semi-circular in cross section, provide a receptacle for an information card or tag inserted in the band and the flattened area of the band facilitates the viewing of the information on the card. A connector is provided which is of substantially elliptical configuration in cross section and includes an abutment intermediate its extremities. The opposite extremities of the connector are receivable in the opposite extremities of the band body and, when inserted in the band body, distend the extremities to correspond to the elliptical configuration of the connector, thus causing a frictional grip to be exerted upon the extremities of the band body. The abutment is engaged on its opposite sides by the respective extremities of the band body and the elliptical perimeter of the abutment constitutes a smooth continuum of the extremities of the band body.
Patent JP-3839483-B2 (JP)
IPC: C12N5/08
Filed: 1996-05-01
Granted: 2006-11-01
Abstract: This invention relates to peptides comprising a helper T cell epitope portion and a B cell epitope portion for eliciting an immune response against endogenous cholesteryl ester transfer protein (CETP) activity, to prevent or treat cardiovascular disease, such as atherosclerosis.
Patent JP-3031720-B2 (JP)
IPC: C12P21/04
Filed: 1996-05-07
Granted: 2000-04-10
Abstract: The invention relates to low-molecular weight, metabolism-activating mixtures of active ingredients from yeast fungi of the order Saccharomycetes and is characterized in that they are obtained from yeasts of the said order of Saccharomycetes, which are cultivated for some hours at temperatures starting at 37° C., are heated to a maximum of 45° C. and, following cooling, are subsequently processed in a manner known per se.
Patent JP-4328387-B2 (JP)
IPC: A61K31/472
Filed: 1997-04-29
Granted: 2009-09-09
Abstract: An entiomeric-enrichment process comprising penicillin amidase resolution of racemic AG3   
The invention also relates to a compound of the formula AG4
Patent PL-162625-B2 (PL)
Title: Gas and coal fired heating boiler
Inventor: NIEMIEC MIECZYSLAW
IPC: F24H1/46
Filed: 1990-03-12
Abstract: 1. Carbon and gas hot water boiler consisting of a fuel chamber, grate for carbon burning ending with a bridge creating, together with the exchanger's wall, a slot connecting the carbon burning chamber to the gas burning chamber, in which a gas burner is situated characterised in that it is equipped with the injection gas burner (9) situated in the gas burning chamber (7) situated below the exchanger (5), and the automatic system (10) sensor (15) is installed on the pipe of overfire air (12) and the amount of overfire air supplied during carbon burning to the burning and after-burning chamber (11) through the slot (6) is regulated with the use of a small flap (14) situated on the wall of the gas burning chamber (7).<IMAGE>